The roots and aerial parts of Eschscholzia californica Cham. (Papaveraceae) were extracted with ethanol. Repeated column chromatography, preparative TLC, and crystallization led to the isolation of fourteen isoquinoline alkaloids, the structures of which were determined on the basis of spectroscopic techniques and by comparison with literature values. One of the compounds isolated, 1-(3-hydroxy-4-methoxybenzyl)-2-methyl-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline (14), has not previously been isolated from a natural source. All isolated compounds were tested for human blood acetylcholinesterase (HuAChE) and human plasma butyrylcholinesterase (HuBuChE) inhibition activity. None of the compounds isolated significantly inhibited both HuAChE and HuBuChE, but the two benzylisoquinoline alkaloids, reticuline 9 and 14, showed promising inhibitory activity against HuBuChE.
Alzheimer´s disease (AD) is the most predominant cause of dementia in the elderly. In AD patients, deficit of cholinergic functions is responsible for the memory impairments [1a] . Acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) are enzymes regulating the level of acetylcholine (ACh) in the brain. AChE plays the main role in the healthy brain, while BuChE displays only a minor role. In patients with AD the level of AChE activity declines with the relative activity of Eschscholzia californica Cham. (Papaveraceae) is a traditional medicinal plant which grows wild in the Pacific regions of North America from Oregon to Mexico. The main medicinal uses of the plant have been as a sedative and anxiolytic [2a] . In folk medicine, the aerial parts were reported to have analgesic, anodyne, diaphoretic, diuretic, soporific and spasmolytic properties [2b]. The whole plant contains a complex mixture of tertiary and quaternary isoquinoline alkaloids with a higher content in the flowering plant. The known alkaloids from E. californica can be subdivided into several constitutional types [2c]. The main alkaloids are pavines, such as californidine and escholtzine, Repeated column chromatography led to the isolation of 14 compounds (1-14). Thirteen of the compounds isolated were known and were identified by comparation of their spectral data with those reported in the literature. These known compounds were identified as a) tertiary alkaloids: (-)-escholtzine (1), protopine (2), allocryptopine (3), (-)-caryachine (4), (-)neocaryachine (5), (-)-O-methylcaryachine (6), (+)-Nmethylarotetanine (7), (-)-argemonine (8) Compound 14, obtained as an amorphous powder, was positive to Dragendorff´s reagent. The ESI-MS revealed a [M+H] + ion at m/z 328.50, corresponding to the molecular formula C 19 H 21 NO 4 . In the 1 H NMR spectrum, two singlets appeared in the aliphatic region, at δ 2.46 (N-CH 3 group), and δ 3.86 (methoxy group). Three methylene groups were observed between δ 2.50-3.22 (δ 3.08-3.22, m, and δ 2.66-2.86, m; H-3: δ 2.66-2.86, m, and δ 2.50-2.61, m; H-4, and δ 2.96-3.08, m, and δ 2.66-2.86, m; benzyl ie. CH 2 ); a methine signal was observed at δ 3.67 (t, J = 6.2 Hz; H-1). Two singlets in the aromatic region can be ascribed to H-5 and H-8 (δ 6.53 and δ 6.25, respectively). Three signals of benzylic phenyl hydrogens were observed, a doublet at δ 6.77 (J = 1.9 Hz; H-2´), a doublet at δ 6.74 (J = 8.2 Hz; H-5´), and a doublet of doublets at δ 6.59 (J = 8.2 and 1.9 Hz; H-6´). In the 1 H NMR spectrum, signals for the -O-CH 2 -O-group were observed (δ 5.87 and 5.85, 2 x d, J = 1.5 Hz). The 13 C NMR spectrum showed 19 carbon resonances [one aliphatic methine group (δ 65.1; C-1), four methylene groups (δ 25.6, C-4; δ 41.0, benzylic CH 2 group; δ 46.5, C-3; and δ 100.5, -OCH 2 O group), and signals for two methyl groups at δ 42.5 (N-CH 3 group) and δ 56.9 (O-CH 3 group)]. The structure of compound 14 as 1-(3-hydroxy-4-methoxybenzyl)-2methyl-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline was unequivocally corroborated by GHMQC correlations (Figure 1 ). This is the first record of alkaloid 14 from a natural source. This structure has been synthesized from S-bulbocapnine by cleavage of the bond between two aromatic moieties [4a] . Escholtzine (1), protopine (2), allocryptopine (3), caryachine (4), O-methylcaryachine (6) , Nmethyllaurotetanine (7), argemonine (8), 7-O-methylether-neocaryachine N-metho salt (12) and californidine (13) have been isolated previously from E. californica [3c,3g], but neocaryachine (5), reticuline (9) scoulerine (10), salutaridine (11), and alkaloid (14) are reported for the first time for this species. Neocaryachine (5) has previously been isolated only once from Cryptocarya chinensis (Lauraceae), which is rich in pavine alkaloids [3a] . Reticuline, scoulerine and salutaridine are common alkaloids that have been isolated from various Papaveraceae species [4b].
Inhibitors of cholinesterase are currently being tested in clinical trials for the treatment of Alzheimer´s disease (AD). AChE inhibitors increase the availability of acetylcholine in central cholinergic synapses and improve memory and cognitive deficits of the patients by diminishing the breakdown of acetylcholine at the synaptic site in the brain. In late AD stages, levels of AChE have declined by up to 85% and BuChE represents the predominant cholinesterase in the brain. For this reason, researchers have targeted BuChE as a new approach to address the progression of AD [1b,5].
The inhibitory activity of alkaloids 1-14 was studied in vitro using the colorimetric method of Ellman et al. [6] . Red blood cells were used as a source of AChE and human plasma of BuChE. The results are expressed as IC 50 values, with galanthamine and huperzine A as positive controls (Table 1) . The IC 50 values of galanthamine were 6.9 ± 0.3 μM for AChE and 156.0 ± 69 μM for BuChE, and of huperzine A 0.25 ± 0.01 μM for AChE. Against BuChE huperzine A was inactive (IC 50 > 1 mM). Of the isolated compounds, the best AChE inhibition was shown by the caryachine (4) and californidine (13), with dose-dependent responses (IC 50 = 19.6 ± 0.4 and 36.7 ± 0.9 μM, respectively). The anti-AChE activity of californidine (61% inhibition of AChE at 10 μM [7] ) and protopine (IC 50 = 16.1 μM [8]), have been described before, but in this case, the source of the enzyme was electric eel. Protopine has also been isolated from mouse brain cortex and showed similar activity (IC 50 = 15.8 ± 1.2 μM, [9] ) as that against AChE from electric eel. The other isolated alkaloids Isoquinoline alkaloids from Eschscholzia californica Natural Product Communications Vol. 5 (7) 2010 1037 displayed either weak or no inhibitory activity against AChE. Promising BuChE inhibition activity was demonstrated by the two benzylisoquinoline alkaloids: reticuline (9) (IC 50 = 43.9 ± 1.1 μM) and alkaloid 14 (IC 50 = 27.8 ± 0.4 μM). Both alkaloids showed higher inhibitory activity than the positive standards, but the other isolated alkaloids were considered inactive.
Experimental
General: 1 H NMR (500 MHz) and 13 C NMR (125.7 MHz) spectra were recorded on a Varian Inova 500 spectrometer, and ESI-MS on a Thermo Finnigan LCQDuo spectrometer. Acetylthiocholine iodide (ATChI), butyrylthiocholine iodide (BuTChI) and 5,5'dithiobis-2-nitrobenzoic acid (DTNB) were purchased from Sigma-Aldrich. Red blood cell ghosts were used as a source of acetylcholinesterase (HuAChE), and human plasma as a source of butyrylcholinesterase (HuBuChE). The IC 50 values were calculated with the use of GraphPad Prism 5.02 software.
Plant material:
Aerial parts and roots of E. californica were obtained from the herbal dealer Planta Naturalis (Markvartice u Sobotky, CZ). A voucher specimen is deposited in the herbarium of the Faculty of Pharmacy at Hradec Králové.
Extraction and isolation:
The dried aerial parts and roots (20 kg) were finely powdered and exhaustively extracted by maceration at room temperature with ethanol (95 %). The solvent was evaporated, the residue (4 L) dissolved in 2% HCl, filtered, the filtrate treated with 10 % NaOH to pH 13, and then exhaustively extracted with CHCl 3 to give 54 g of tertiary alkaloids (fraction A). The strongly polar alkaloids were obtained in the form of iodides, after addition of potassium iodide and extraction with chloroform [2c]. This fraction of quaternary alkaloids was marked as fraction B. Fraction A (54 g) was subjected to silica gel CC using step gradient elution with CHCl 3 -EtOH (100:1, 97:3, 95:5, 9:1, 85:15, 8:2, 75:25, 7:3, 65:35, 6:4, 55:45, and 1:1, 5000 mL each) to afford 10 fractions (A1-A10). Fraction A1 gave compound 1 (6.52 g). Fraction A2 was chromatographed further on a silica gel column using step gradient elution with CHCl 3 -EtOH (10:1 and 5:1) to give compounds 2 (6.25 g) and 3 (2.75 g). Compounds 4 (60 mg) and 7 (240 mg) were obtained from fractions A3/A4 by preparative TLC eluting with toluene: Et 2 NH 2 (95:5). Fraction A5 was further chromatographed on silica gel (CHCl 3 : EtOH, 9:1) to give compound 5 and subfraction A5/1. Preparative TLC (n-hexane: Et 2 NH 2 , x 3) of subfraction A5/1 gave compounds 6 (155 mg) and 8 (75 mg). Fractions A/6-A/8 were further subjected to preparative TLC (toluene: Et 2 NH 2 , 95:5, x 2) to give compounds 7 (250 mg), 9 (70 mg), 10 (170 mg), 11 (34 mg), and 14 (42 mg).
Fraction B (160 g) was subjected to Al 2 O 3 CC and eluted with a step gradient of benzene: CHCl 3 (9:1, 8:2, 7:3, 6:4 and 1:1, 6000 mL each). Four subfractions were obtained (B1-B4). Subfraction B1 was subjected to preparative TLC (Al 2 O 3 , mobile phase CHCl 3 : EtOH 97:3, x 2), which led to the isolation of compound 12 (135 mg). Recrystallization of subfractions B2-B4 from EtOH gave 15.65 g of compound 13.
Preparation of red blood cells ghosts:
Ghosts were prepared from freshly drawn blood (taken from healthy volunteers), to which 1 mL of sodium citrate per 10 mL of blood was added, according to the method of Steck and Kant [10] , with slight modification. Briefly plasma (HuBuChE) was removed from the whole blood by centrifugation at 4000 rpm in a Boeco U-32R centrifuge with a Hettich 1611 rotor. Red blood cells were transferred to 50 mL tubes and washed 3 times with 5 mM phosphate buffer (pH 7.4) containing 150 mM sodium chloride (12,000 rpm, Avanti J-30I, rotor JA-30.50). The washed erythrocytes were stirred with 5 mM phosphate buffer (pH 7.4) for 10 mins to ensure lysis. The lysed cells were centrifuged at 20,000 rpm for 10 mins and then the ghosts (HuAChE) were washed 3 times with phosphate buffer.
Acetylcholinesterase and butyrylcholinesterase assay:
HuAChE and HuBuChE activities were determined with a modified method of Ellman et al., [6] using acetylthiocholine and butyrylthiocholine as substrates, respectively. Briefly, 25-50 μL of either ghosts or plasma, 650 μL of DTNB and 25 μL of either the sample or appropriate solvent, as a blank sample, were added to the semi-micro cuvette. The reaction was initiated by addition of substrate (ATChI or BuTChI). The final proportion of DTNB to substrate was 1:1. The increase of absorbance at 436 nm (∆A) was measured for 1 min using a Shimadzu UV-1611 spectrophotometer. Each measurement was repeated 3 times. The % inhibition was calculated according to the formula: %I = 100-(∆A BL /∆A SA )*100, where ∆A BL is increase of absorbance of blank sample and ∆A SA is increase of absorbance of the measured sample. 
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